Cocrystal Pharma COCP
NASDAQ COCP
$1.16 +0.02 (+1.75%)
At close: Oct 2, 2026 · 4:00 PM EDT

Cocrystal Pharma (COCP) Income from Discontinued Operations (2012 - 2013)

Updated

Cocrystal Pharma's Income from Discontinued Operations was -$8.86 million in Q4 2013, compared with -$437,644 a year earlier.

Analysis

Cocrystal Pharma (COCP) Income from Discontinued Operations (2012 - 2013) Analysis & Trends

For FY2013, Income from Discontinued Operations at Cocrystal Pharma came in at -$8.65 million.

  • In earlier years, Income from Discontinued Operations was -$333,412 in FY2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 Cocrystal Pharma 16.00 Mn -5.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 -8.86 Mn
Sep 30, 2013 64,058.00
Dec 31, 2012 -437,644.00
Sep 30, 2012 23,810.00
API Access

Cocrystal Pharma Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=COCP&period=max&api_key=YOUR_API_KEY